Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Core Laboratories N-V (CLB) stocks in Canada
Learn how to easily invest in Core Laboratories N-V stocks.
Core Laboratories N-V is an oil & gas equipment & services business based in the US. Core Laboratories N-V stocks (CLB.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $36.11 – an increase of 2.08% over the previous week. Core Laboratories N-V employs 3,700 staff and has a trailing 12-month revenue of around $458.9 million.
How to buy shares in Core Laboratories N-V
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CLB – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Core Laboratories N-V?
- Has coronavirus impacted Core Laboratories N-V shares?
- Core Laboratories N-V shares summary
- Compare share dealing platforms
- Is Core Laboratories N-V stock a buy or sell?
- Core Laboratories N-V performance over time
- Are Core Laboratories N-V shares over-valued?
- Core Laboratories N-V's financials
- How volatile are Core Laboratories N-V shares?
- Does Core Laboratories N-V pay a dividend?
- Have Core Laboratories N-V shares ever split?
- Other common questions
Core Laboratories N-V stock price (NYSE:CLB)Use our graph to track the performance of CLB stocks over time.
Core Laboratories N-V shares at a glance
|Latest market close||$26.45|
|52-week range||$21.08 - $49.84|
|50-day moving average||$24.68|
|200-day moving average||$30.48|
|Wall St. target price||$27.50|
|Dividend yield||$0.04 (0.15%)|
|Earnings per share (TTM)||$0.67|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Core Laboratories N-V stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Core Laboratories N-V price performance over time
|1 week (2022-01-21)||2.08%|
|1 month (2021-12-29)||15.50%|
|3 months (2021-10-29)||1.69%|
|6 months (2021-07-29)||-20.97%|
|1 year (2021-01-29)||-19.80%|
|2 years (2020-01-29)||-25.83%|
|3 years (2019-01-29)||67.16|
|5 years (2017-01-27)||116.7|
Is Core Laboratories N-V under- or over-valued?
Valuing Core Laboratories N-V stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Core Laboratories N-V's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Core Laboratories N-V's P/E ratio
Core Laboratories N-V's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 40x. In other words, Core Laboratories N-V shares trade at around 40x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Core Laboratories N-V's PEG ratio
Core Laboratories N-V's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.5197. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Core Laboratories N-V's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Core Laboratories N-V's EBITDA
Core Laboratories N-V's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $60.8 million.
The EBITDA is a measure of a Core Laboratories N-V's overall financial performance and is widely used to measure a its profitability.
Core Laboratories N-V financials
|Revenue TTM||$458.9 million|
|Operating margin TTM||9.13%|
|Gross profit TTM||$102.1 million|
|Return on assets TTM||4.45%|
|Return on equity TTM||2765.47%|
|Market capitalisation||$1.2 billion|
TTM: trailing 12 months
Core Laboratories N-V share dividends
Dividend payout ratio: 4.35% of net profits
Recently Core Laboratories N-V has paid out, on average, around 4.35% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.15% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Core Laboratories N-V shareholders could enjoy a 0.15% return on their shares, in the form of dividend payments. In Core Laboratories N-V's case, that would currently equate to about $0.04 per share.
While Core Laboratories N-V's payout ratio might seem low, this can signify that Core Laboratories N-V is investing more in its future growth.
Core Laboratories N-V's most recent dividend payout was on 28 November 2021. The latest dividend was paid out to all shareholders who bought their shares by 4 November 2021 (the "ex-dividend date").
Have Core Laboratories N-V's shares ever split?
Core Laboratories N-V's shares were split on a 2:1 basis on 8 July 2010. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Core Laboratories N-V shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Core Laboratories N-V shares which in turn could have impacted Core Laboratories N-V's share price.
Core Laboratories N-V share price volatility
Over the last 12 months, Core Laboratories N-V's shares have ranged in value from as little as $21.08 up to $49.8352. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Core Laboratories N-V's is 3.0233. This would suggest that Core Laboratories N-V's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Core Laboratories N-V overview
Core Laboratories N. V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products; and proprietary and joint industry studies. The Production Enhancement segment offers services and products relating to reservoir well completions, perforations, stimulations, and production.
Core Laboratories N-V in the news
Country Trust Bank Buys Consumer Discretionary Select Sector SPDR, PayPal Holdings Inc, MasTec ...
Core Laboratories (CLB) Reports Next Week: Wall Street Expects Earnings Growth
What to watch today: Wall Street to open lower after Nasdaq's worst week since March 2020
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Silver Spike Investment Corp. (SSIC) stock in Canada when it goes public
Everything we know about the Silver Spike Investment Corp. IPO, plus information on how to buy in.
How to buy MOD Pizza stock in Canada when it goes public
Everything we know about the MOD Pizza IPO, plus information on how to buy in.
How to buy Modular Medical (MODD) stock in Canada when it goes public
Everything we know about the Modular Medical IPO, plus information on how to buy in.
How to buy Direct Digital Holdings (DRCT) stock in Canada when it goes public
Everything we know about the Direct Digital Holdings IPO, plus information on how to buy in.
How to buy TC BioPharm (TCBP) stock in Canada when it goes public
Everything we know about the TC BioPharm IPO, plus information on how to buy in.
How to buy Maris-Tech Ltd (MTEK) stock in Canada when it goes public
Everything we know about the Maris-Tech Ltd IPO, plus information on how to buy in.
How to buy Phoenix Motor (PEV) stock in Canada when it goes public
Everything we know about the Phoenix Motor IPO, plus information on how to buy in.
How to buy Nauticus Robotics, Inc. (KITT) stock in Canada when it goes public
Everything we know about the Nauticus Robotics, Inc. IPO, plus information on how to buy in.
What is Mogo and how can you access its new trading platform, MogoTrade? Find out in our review.
Lido’s liquid staking allows investors holding LUNA and less than 32 ETH to reap the rewards of DeFi staking.